Investigating the effects of RSV vaccination during pregnancy on infant health outcomes
Official title: Neonatal, Lactation, and Child Health Outcomes Following RSV Vaccination During Pregnancy
Funded at Healthpartners Institute · NIH-11166631 · Data updated 2026-11-12
This study is looking at how getting the RSV vaccine while pregnant can help keep newborns and young kids healthy, especially for moms at higher risk of having preterm babies, and it aims to reassure pregnant women about the vaccine's safety and benefits for their little ones.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Healthpartners Institute NIH-funded |
| Lab location | 1 site (Bloomington, UNITED STATES) |
| Project start | August 9, 2024 |
| Project end | April 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $681,509 |
| NIH project number | 5R01HD115580-02 |
| Project ID | NIH-11166631 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include pregnant individuals, particularly those who are at high risk for preterm birth, who are considering or have received the RSV vaccine.
✕Less likely to help
Patients who are not pregnant or those who do not plan to have children in the near future may not benefit from this research.
What this research studies
This research examines how receiving the RSV vaccine during pregnancy affects the health of newborns and young children. It focuses on understanding the safety and effectiveness of the vaccine, particularly for mothers at high risk for preterm birth and its impact on breastfeeding and long-term child development. By collecting real-world data, the study aims to address concerns about the vaccine's safety and improve confidence in its use among pregnant individuals. Participants will be monitored for various health outcomes in their infants, including growth and allergic conditions.
Why it matters
Potential benefit: If successful, this research could enhance the safety profile of the RSV vaccine, leading to increased vaccination rates and better health outcomes for infants.
How similar studies have gone: Previous research has shown promising results regarding the safety and efficacy of vaccines during pregnancy, but this specific investigation into RSV vaccination is novel and aims to fill existing knowledge gaps.
Where this research is happening
-
Healthpartners Institute
Bloomington, United States Active
Researchers
- Principal investigator: Palmsten, Kristin — Healthpartners Institute
- Study coordinator: Palmsten, Kristin
Related research
Other NIH-funded projects on the same topics.
-
Pregnancy RSV vaccine effects on newborns, breastfeeding, and child health
This project looks at whether getting the RSV vaccine during pregnancy affects newborn health, breastfeeding, growth, development, and allergic outcomes in early childhood.
-
Iodized salt and early brain development in babies of pregnant and breastfeeding women in rural Ethiopia
This grant tests whether giving iodized salt to pregnant and breastfeeding women helps their babies’ brain development.
-
IMPILO: New 6-month RR-TB regimen in pregnant and breastfeeding women
A study in pregnant and postpartum women with rifampicin-resistant TB will track how well a new all-oral 6-month treatment works and how well people stick to it.
-
Effects of iodized salt during pregnancy and breastfeeding on infant brain development in rural Ethiopia
Pregnant and breastfeeding people in rural Ethiopia will receive iodized salt to see how it affects their baby’s brain development.
-
Iodized salt for pregnant and breastfeeding mothers to support babies' brain development in rural Ethiopia
This project gives iodized salt to pregnant and breastfeeding women in rural Ethiopia to see if it helps their babies' early brain, attention, and motor development.
-
Effects of restricting non-nutritive sweeteners during pregnancy on infant growth
A study will test whether limiting non-nutritive sweeteners in pregnant and breastfeeding mothers affects how babies eat, grow, and develop in the first two years.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.